secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K/A
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001104659-24-130803
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud

Cara Therapeutics files amended 8-K to correct investor presentation for proposed merger with Tvardi Therapeutics
--------------------------------------------------------------------------------

- Merger agreement with Tvardi Therapeutics and merger sub was signed on December 17, 2024.
- Asset Purchase Agreement with Vifor Fresenius Medical Care Renal Pharma for disposition of assets was signed on December 17, 2024.
- Stockholder support agreements and lock-up agreements were filed with the SEC on December 17, 2024.
- This amendment corrects formatting errors in the investor presentation originally filed on December 18, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465924130803/0001104659-24-130803-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465924130803/tm2431662d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-130803

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer